These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7303725)
1. Species differences in the disposition and metabolism of sulfinpyrazone. Dieterle W; Faigle JW Xenobiotica; 1981 Aug; 11(8):559-68. PubMed ID: 7303725 [TBL] [Abstract][Full Text] [Related]
2. New metabolites of sulfinpyrazone in man. Dieterle W; Faigle JW; Moppert J Arzneimittelforschung; 1980; 30(6):989-93. PubMed ID: 7191279 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of single doses of sulphinpyrazone and its major metabolites in plasma and urine. Bradbrook ID; John VA; Morrison PJ; Rogers HJ; Spector RG Br J Clin Pharmacol; 1982 Feb; 13(2):177-85. PubMed ID: 7059415 [TBL] [Abstract][Full Text] [Related]
4. Biotransformation and pharmacokinetics of sulfinpyrazone (Anturan) in man. Dieterle W; Faigle JW; Mory H; Richter WJ; Theobald W Eur J Clin Pharmacol; 1975 Dec; 9(2-3):135-45. PubMed ID: 786687 [TBL] [Abstract][Full Text] [Related]
5. Disposition and metabolism of fenbufen in several laboratory animals. Chiccarelli FS; Eisner HJ; Van Lear GE Arzneimittelforschung; 1980; 30(4A):707-15. PubMed ID: 6776965 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105. Mukai H; Sugimoto T; Ago M; Morino A Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039 [TBL] [Abstract][Full Text] [Related]
7. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man. Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544 [TBL] [Abstract][Full Text] [Related]
8. Metabolic disposition of 6-ethyl-3-(1H-tetrazol-5-yl)-chromone, a new antiallergic agent, in the rat, guinea-pig, rabbit, dog and monkey. Kanai Y; Nakai Y; Nakajima N; Tanayama S Xenobiotica; 1979 Jan; 9(1):33-50. PubMed ID: 104449 [TBL] [Abstract][Full Text] [Related]
9. Effect of salicylate on the fate of [14C]sulfinpyrazone in the rat. Wong LT; Buttar HS; Solomonraj G; Thomas BH Can J Physiol Pharmacol; 1982 Jun; 60(6):763-8. PubMed ID: 7116223 [TBL] [Abstract][Full Text] [Related]
10. The site of reduction of sulphinpyrazone in the rabbit. Strong HA; Renwick AG; George CF Xenobiotica; 1984 Oct; 14(10):815-26. PubMed ID: 6506754 [TBL] [Abstract][Full Text] [Related]
11. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans. Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130 [TBL] [Abstract][Full Text] [Related]
12. Blood level, distribution, excretion, and metabolite pattern of [14C]-brotizolam in the rat, dog, and rhesus monkey. Bechtel WD; Mierau J; Richter I; Stiasni M Arzneimittelforschung; 1986 Mar; 36(3A):568-74. PubMed ID: 3718579 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine. Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298 [TBL] [Abstract][Full Text] [Related]
15. The effect of sulphinpyrazone and its metabolites on platelet function in vitro and ex vivo. Pay GF; Wallis RB; Zelaschi D Haemostasis; 1981; 10(3):165-75. PubMed ID: 7262645 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound. Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556 [TBL] [Abstract][Full Text] [Related]
17. Correlation between inhibitory effect on platelet aggregation and disposition of sulfinpyrazone and its metabolites in rabbits. Part I: Single dose study. Ritschel WA; Kuo BS Biopharm Drug Dispos; 1987; 8(1):1-9. PubMed ID: 3107626 [TBL] [Abstract][Full Text] [Related]
18. Disposition of caspofungin, a novel antifungal agent, in mice, rats, rabbits, and monkeys. Sandhu P; Xu X; Bondiskey PJ; Balani SK; Morris ML; Tang YS; Miller AR; Pearson PG Antimicrob Agents Chemother; 2004 Apr; 48(4):1272-80. PubMed ID: 15047529 [TBL] [Abstract][Full Text] [Related]